Avid Bioservices, Inc. (CDMO) Social Stream
Avid Bioservices Inc (CDMO) Price Targets From Analysts
Use the tables below to see what analysts covering Avid Bioservices Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
CDMO's average price target has moved up $11.17 over the prior 37 weeks.
Over the past 38 weeks, CDMO's average upside potential has been 19.77%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CDMO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 44 weeks, CDMO's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CDMO as an investment opportunity.
- In the context of all US stocks, Avid Bioservices Inc's variance in analysts' estimates is lower than 35.51% of them.
- CDMO has a higher number of analysts covering the stock than 87.46% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Avid Bioservices Inc's upside potential (average analyst target price relative to current price) is greater than 97.53% of them.
- In the context of stocks in the small market cap category, Avid Bioservices Inc's average analyst price target is higher than 345.76% of them.
In the Pharmaceutical Products industry, CBIO, CBAY, and CARA are the three stocks most similar to Avid Bioservices Inc regarding the price target and analyst recommendation information presented here.
Is CDMO a Buy, Hold or Sell? See the POWR Ratings now!